Ciprofloxacin was given perorally in two doses of 750 mg each with a 12-h interval starting 24 h prior to surgery, 400 mg of ciprofloxacin was given intravenously at the induction of anesthesia, and 400 mg of ciprofloxacin was given 12 h later to 21 patients undergoing elective colorectal surgery. The maximum concentrations in serum (mean value + standard deviation, 11.1 + 7.8 mg/liter) during surgery were reached 30 min after ciprofloxacin was administered. The ciprofloxacin concentrations in the intestinal mucosa samples were 2.7 to 37.8 mg/kg of tissue weight, and the concentrations in the fecal samples were <0.1 to 858 mg/kg. The aerobic and anaerobic bacteria in the fecal flora were suppressed markedly during the prophylaxis period. No postoperative infections occurred.
Infections are responsible for the majority of postoperative surgical complications. The utility of antimicrobial agents in preventing infections complicating surgery has been demonstrated in many published studies during the last 10 years. Prospective controlled studies have indicated that a short course of selected systemic antimicrobial agents in the perioperative period can significantly reduce the rate of wound infection and prevent the development of local and systemic postoperative infectious complications.
Ciprofloxacin has been shown to be active against aerobic gram-negative rods and aerobic gram-positive cocci, while its activity against anaerobes has been reported to be lower (2) .
The purpose of this study was to obtain data about concentrations of ciprofloxacin in serum, intestinal mucosa, and feces and about the effects of ciprofloxacin on the colon microflora and on infectious complications in patients undergoing elective colorectal surgery.
A total of 21 patients, 10 men and 11 women between 47 and 86 years old (median age, 68 years), undergoing elective colorectal surgery were included in the trial. There were 17 patients with colorectal cancers, 2 with diverticulosis, 1 with a prolapse, and 1 with a polyp. Preoperative preparation including fluid diet and daily enemas was carried out for 72 h. All patients underwent bowel restrictions. Postoperative infections were registered by the method of Ljungqvist (6) .
Ciprofloxacin was given perorally in two doses of 750 mg each with a 12-h interval starting 24 h prior to surgery, 400 mg of ciprofloxacin was given as an intravenous infusion over 30 min beginning at the induction of anesthesia, and 400 mg of ciprofloxacin was given 12 h later.
On the day of surgery, blood samples were taken prior to the first intravenous dose of ciprofloxacin and at 0.5, 1, 2, 3, 4, 6 and 8 h after administration. During the operation, samples of mucosal tissue and feces were collected from the intestine. The blood samples were immediately centrifuged, and serum was withdrawn. The intestinal mucosa was prepared free from muscles, and superficial blood was wiped off. All samples were immediately frozen and assayed within 2 weeks. * Corresponding author.
The concentrations of ciprofloxacin were determined by the microbiological agar diffusion method with agar wells 4 mm in diameter as diffusion centers. The medium used was Mueller-Hinton agar, pH 7.4 , and the test strain was Escherichia coli KP. From a standard stock solution of ciprofloxacin, daily working solutions were prepared in pooled human serum for serum assays and in phosphate buffer for assays of mucosa and feces. The method had a quantitation limit of 0.1 mg/liter. The reproducibility and variability of the assays were not greater than 3% at a 95% confidence limit.
Standard curves were calculated by linear regression of inhibition zones on log test concentrations. Serum half-lives were calculated by linear regression of log concentrations over time. The area under the serum concentration-time curve was calculated by the trapezoidal rule. The area beyond the last sampling point was estimated as the last concentration measured divided by the elimination rate constant, assuming first-order kinetics.
Stool specimens for microbiological studies were taken from the colonic drainage on the day before the operation, daily for 5 days after surgery, and then at 2 and 4 weeks after surgery. The specimens were collected in the morning in sterile plastic containers. The containers were placed in ice chests and transported to the laboratory as soon as possible. The specimens were suspended in prereduced peptone-yeast extract medium, diluted, and inoculated on selective media (5) . The aerobic agar plates were incubated for 24 h at 37°C, and the anaerobic plates were incubated for 48 h at 37°C in anaerobic jars (GasPak; BBL Microbiology Systems). After incubation, different colony types were counted, isolated in pure culture, and identified to genus level by using morphological and biochemical tests and gas-liquid chromatography. The lower limit of detection was 102 microorganisms per g of feces.
The maximum levels in serum varied from 4.6 to 41.2 mg/liter (mean + standard deviation, 11.1 + 7.8 mg/liter) and were observed 0.5 h after administration. The mean half-life was 3.7 h, and the mean area under the serum concentrationtime curve was 31.0 + 10.7 mg -h/liter (mean + standard deviation). The mean ciprofloxacin concentration in intestinal mucosa (day 1) was 11.9 ± 8.9 mg/kg of tissue weight (mean ± standard deviation; range, 2.7 to 37.8 mg/kg). The ANTIMICROB. AGENTS CHEMOTHER. Table 1 . No correlation between the concentrations in serum, mucosa, and feces in the individual patients were observed. The impact of ciprofloxacin on the aerobic colon microflora is shown in Fig. 1 . During the ciprofloxacin administration period, the numbers of streptococci, enterococci, and enterobacteria decreased markedly. Numbers of enterococci returned to normal after 2 weeks, while enterobacteria returned to pretreatment levels in most patients within 4 weeks. Ciprofloxacin also caused marked changes in the anaerobic colon microflora (Fig. 2) . Both gram-positive and gram-negative anaerobic bacteria-cocci, bifidobacteria, eubacteria, lactobacilli, clostridia, fusobacteria, and bacteroides-were suppressed markedly during the first 3 days. After 2 weeks, the anaerobic microflora returned to the same levels as before the ciprofloxacin was administered.
No postoperative infections occurred, and no adverse effects were registered.
Many publications have established that ciprofloxacin is characterized by high levels of tissue penetration after both oral and parenteral administration (3, 10) . Only a few data, however, about the concentration of ciprofloxacin in the human gut have been published. Silverman and co-workers (8) found concentrations above 5 mg/liter in the jejunum wall after a dose of 200 mg of ciprofloxacin. In the present study, the concentrations in mucosa of the colons in 21 patients were determined. The concentrations were measured during steady state because the patients had received two doses of ciprofloxacin orally 1 day before the intravenous infusion. In all patients except two, the concentrations of ciprofloxacin in mucosa exceeded the corresponding concentrations in serum. The high concentrations of ciprofloxacin in mucosa and in feces were probably a result of accumulation. This is in contrast with similar studies of other antimicrobial agents, in which the concentrations in mucosa were measured after an initial intravenous dose (7) . After this measurement, the mucosa concentration/serum concentration ratios were fairly constant during the observation period and there was no accumulation in the tissues. The concentrations of ciprofloxacin in serum in patients undergoing surgery seemed similar to those in healthy volunteers (9) . Our results have been obtained by a microbiological bioassay method, and there is good agreement between the microbiological method and the high-pressure liquid chromatography method (1) . The great variability in levels in serum and tissue may be due to the types of patients and diseases.
The present investigation demonstrated that ciprofloxacin was active against both aerobic and anaerobic bacteria in the lower intestinal tract, in contrast to reports which show that only the aerobic gram-negative microflora is suppressed by ciprofloxacin administration (4) . The MICs for most aerobic and anaerobic bacteria (2) . The pronounced effect of ciprofloxacin on the colon microflora can therefore be partly explained by the antibacterial spectrum of ciprofloxacin and the concentration of ciprofloxacin in the intestinal mucosa. No new colonizing ciprofloxacinresistant bacteria were observed during the investigation period, and the microflora levels were almost normal within 2 weeks. On the basis of present findings, ciprofloxacin may be useful as a single prophylactic agent in colorectal surgery and therefore deserves further clinical investigation. Comparisons between ciprofloxacin and other agents recommended for prophylaxis in colorectal surgery should then be made.
